Line 20: Line 20:       −
There are two antigenically distinct<sup.9</sup> genotypes of BVDV, type 1 and type 2, which are most accurately characterised based on sequence variation. 11 and 3 subtypes exist within BVDV-1 and BVDV-2 respectively, which have been demonstrated by analysis of the 5’UTR<sup>10</sup>. Despite the large antigenic differences between the genotypes, cross-protection against type 2 viruses is afforded by type 1 vaccines<sup>11, 12, 13</sup>.
+
There are two antigenically distinct<sup>9</sup> genotypes of BVDV, type 1 and type 2, which are most accurately characterised based on sequence variation. 11 and 3 subtypes exist within BVDV-1 and BVDV-2 respectively, which have been demonstrated by analysis of the 5’UTR<sup>10</sup>. Despite the large antigenic differences between the genotypes, cross-protection against type 2 viruses is afforded by type 1 vaccines<sup>11, 12, 13</sup>.
    
A split in virulence between genotypes is evident. BVDV1 species, including classical strains and common vaccine strains, tend to cause milder disease (Deregt, 2004) and are found worldwide. Alternatively, BVDV2 isolates typically cause more severe disease, characterised by fever, diarrhoea, thrombocytopaenia, haemorrhage, respiratory signs, and high abortion and mortality rates (Corapi et al., 1989; Carman et al, 1998). These viruses were first reported in Canada and the USA, although their distribution is widening. The first British case of type 2 BVDV was identified in 2002 (Drew et al., 2002).
 
A split in virulence between genotypes is evident. BVDV1 species, including classical strains and common vaccine strains, tend to cause milder disease (Deregt, 2004) and are found worldwide. Alternatively, BVDV2 isolates typically cause more severe disease, characterised by fever, diarrhoea, thrombocytopaenia, haemorrhage, respiratory signs, and high abortion and mortality rates (Corapi et al., 1989; Carman et al, 1998). These viruses were first reported in Canada and the USA, although their distribution is widening. The first British case of type 2 BVDV was identified in 2002 (Drew et al., 2002).
6,502

edits